Manhattan Hematology Oncology — New York, New York

Manhattan Hematology Oncology is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 46/100 (POOR). This profile has not yet been claimed by the site owner.

Manhattan Hematology Oncology has participated in 1 clinical trials.

Therapeutic areas: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Non-Hodgkin's Lymphoma.

Sponsors: Aptose Biosciences Inc..

Sponsor Feasibility Report

Trust Score: 46/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Manhattan Hematology Oncology?

Manhattan Hematology Oncology has a Crixeo Trust Score of 46/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Manhattan Hematology Oncology conducted?

Manhattan Hematology Oncology has 1 clinical trials on record. Their work covers Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Non-Hodgkin's Lymphoma.

Is Manhattan Hematology Oncology accredited by Crixeo Health?

Manhattan Hematology Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Manhattan Hematology Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.